LexOrbis reports that Ranbaxy Laboratories Ltd, India’s leading drug maker has recently settled a patent dispute with Takeda Pharmaceutical Company Ltd. The dispute related to the generic version of diabetes drug, Actos, in the United States. Ranbaxy produces a wide range of affordable and quality generic medicines having a huge focus on R&D. It has obtained several approvals in developed markets and significant progress in New Drug Discovery Research. On the other hand, Takeda is a research-based global pharmaceutical company, based in Japan. Takeda's in-house ethical drugs are marketed in around 90 countries worldwide and are recognized as the brand in major countries worldwide.

OUVRIR MON COMPTE CREATE MY ACCOUNT

  Un problème avec cet article ? / A problem with this article?